First Header Logo Second Header Logo

Connection

Karl-Erik Andersson to Ejaculation

This is a "connection" page, showing publications Karl-Erik Andersson has written about Ejaculation.
Connection Strength

0.997
  1. Andersson KE, Abdel-Hamid IA. Therapeutic targets for premature ejaculation. Maturitas. 2011 Sep; 70(1):26-33.
    View in: PubMed
    Score: 0.352
  2. Abdel-Hamid IA, Jannini EA, Andersson KE. Premature ejaculation: focus on therapeutic targets. Expert Opin Ther Targets. 2009 Feb; 13(2):175-93.
    View in: PubMed
    Score: 0.296
  3. Andersson KE, Mulhall JP, Wyllie MG. Pharmacokinetic and pharmacodynamic features of dapoxetine, a novel drug for 'on-demand' treatment of premature ejaculation. BJU Int. 2006 Feb; 97(2):311-5.
    View in: PubMed
    Score: 0.240
  4. Andersson KE, Gratzke C. Pharmacology of alpha1-adrenoceptor antagonists in the lower urinary tract and central nervous system. Nat Clin Pract Urol. 2007 Jul; 4(7):368-78.
    View in: PubMed
    Score: 0.066
  5. Abdel-Hamid IA, Andersson KE, Salonia A. Exploration of therapeutic targets for sexual dysfunctions: lessons learned from the failed stories. Expert Opin Ther Targets. 2011 Mar; 15(3):325-40.
    View in: PubMed
    Score: 0.021
  6. Burnett AL, Goldstein I, Andersson KE, Argiolas A, Christ G, Park K, Xin ZC. Future sexual medicine physiological treatment targets. J Sex Med. 2010 Oct; 7(10):3269-304.
    View in: PubMed
    Score: 0.021
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.